The hypereosinophilic syndrome revisited - PubMed (original) (raw)

Review

The hypereosinophilic syndrome revisited

Florence Roufosse et al. Annu Rev Med. 2003.

Abstract

Clinical and biological features of patients with the idiopathic hypereosinophilic syndrome (HES) are heterogeneous. Recent evidence suggests at least two distinct underlying hematological disorders involving myeloid and lymphoid cells, respectively. We therefore suggest that the term idiopathic should be abandoned in the classification of HES. This review defines the "myeloproliferative" and "lymphocytic" variants of the HES and addresses the management of each variant, focusing on diagnosis and treatment of the newly identified lymphocytic variant.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances